학술논문
Gefitinib (G) treatment outcome after progression on erlotinib (E) in patients with advanced non-small-cell lung cancer (NSCLC).
Document Type
Article
Author
Source
Journal of Thoracic Oncology; 2007 Supplement 4, Vol. 2, pS716-S717, 2p
Subject
Language
ISSN
15560864